Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 54 for

Edit search filters
  1. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis

    Rochester, MN

  2. Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and in Combination, in Participants With Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)

    Rochester, MN

  3. A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury

    Scottsdale/Phoenix, AZ

  4. A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis

    Scottsdale/Phoenix, AZ

  5. A Study of Erlotinib as a Prevention in Trisomy 7 Positive Primary Sclerosing Cholangitis

    Rochester, MN

  6. Liver Cirrhosis Network Cohort Study (LCN-C)

    Rochester, MN

  7. A Study to Evaluate Voice-enabled Artificial Intelligence to Diagnosis Hepatic Encephalopathy

    Rochester, MN

  8. A Study of Outpatients with Cirrhosis

    Rochester, MN, Scottsdale/Phoenix, AZ

  9. A Study of the Development and Validation of an Ascites-Specific Patient Reported Outcomes Questionnaire

    Rochester, MN

  10. Validation of Cognitive Tests in Elderly Cirrhotic Patients

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer